News for '-us-food'

Investors concerned about Wockhardt

Investors concerned about Wockhardt

Rediff.com17 Oct 2013

The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.

Ranbaxy brands to stay alive

Ranbaxy brands to stay alive

Rediff.com8 Aug 2014

Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit.

What the BCCI can learn from Jungle Book

What the BCCI can learn from Jungle Book

Rediff.com13 Apr 2016

The fictional characters in the movie knew that water was of utmost importance. This is something that the BCCI continues to ignore as they insist that IPL matches, be played in the drought-hit state, writes Rediff com's Syed Firdaus Ashraf.

'US FDA not on a witch hunt against India pharma firms'

'US FDA not on a witch hunt against India pharma firms'

Rediff.com23 Sep 2013

This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy

Sensex, Nifty at their lowest close in 2015; bluechips drag

Sensex, Nifty at their lowest close in 2015; bluechips drag

Rediff.com8 Jun 2015

Markets ended their lowest close in 2015 on fears of FII outflows as the US Fed may hike rates.

Lapses by some pharma cos overshadowed good things: FDA chief

Lapses by some pharma cos overshadowed good things: FDA chief

Rediff.com12 Feb 2014

On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.

Sensex drops 371 points to end at 1-week low; financial shares drag

Sensex drops 371 points to end at 1-week low; financial shares drag

Rediff.com28 Mar 2016

The S&P BSE Sensex ended down 371 points at 24,966 and the Nifty50 closed 101 points lower at 7,615.

Samvat 2072: Auto sector could see faster recovery

Samvat 2072: Auto sector could see faster recovery

Rediff.com11 Nov 2015

Samvat 2072: Auto sector could see faster recovery

Markets lose glitter ahead of Diwali as Bihar, US Fed play spoilsport

Markets lose glitter ahead of Diwali as Bihar, US Fed play spoilsport

Rediff.com10 Nov 2015

Sensex,Nifty to remain under pressure through the week.

Why are domestic investors writing off pharma stocks these days

Why are domestic investors writing off pharma stocks these days

Rediff.com19 May 2015

FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.

Earning woes drag markets lower; TCS, HUL lead fall

Earning woes drag markets lower; TCS, HUL lead fall

Rediff.com14 Oct 2015

Earning woes drag markets lower; TCS, HUL lead fall.

Sensex, Nifty rise 1% as Fed keeps interest rates unchanged

Sensex, Nifty rise 1% as Fed keeps interest rates unchanged

Rediff.com22 Sep 2016

Rate-sensitive sectors like banks, auto and realty witnessed strong buying demand in trades today

Sensex ends over 200 points lower on weak European cues

Sensex ends over 200 points lower on weak European cues

Rediff.com28 Sep 2015

Investors will maintain a cautious stance.

Dr Reddy's sued for patent 'infringement'

Dr Reddy's sued for patent 'infringement'

Rediff.com19 Jun 2013

The US Drug maker requested the court to pass an order to restrain DRL from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing DRL's generic paricalcitol injectable products prior to the expiration of said patents.

What lies ahead for Sun Pharma post Ranbaxy merger approval

What lies ahead for Sun Pharma post Ranbaxy merger approval

Rediff.com31 Mar 2015

Sun Pharmaceutical's acquisition of Ranbaxy has received final approvals.

Ranbaxy buy in line with Sun's strategy

Ranbaxy buy in line with Sun's strategy

Rediff.com17 Apr 2014

The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.

FULL TEXT of PM Modi's I-Day address

FULL TEXT of PM Modi's I-Day address

Rediff.com15 Aug 2019

Following is the full text of Prime Minister Narendra Modi's address from the ramparts of the Red Fort on the 73rd Independence Day.

Sklamberg on challenges the US drug regulator faces globally

Sklamberg on challenges the US drug regulator faces globally

Rediff.com19 Mar 2015

The US Food and Drug Administration (FDA) says it does not follow an India agenda.

'Ranbaxy got USFDA nod with no data or fraudulent data'

'Ranbaxy got USFDA nod with no data or fraudulent data'

Rediff.com7 Nov 2013

In May this year, Ranbaxy had pleaded guilty to 'felony charges' for violating manufacturing norms and agreed to pay $500 million penalty to US authorities.

Markets trip on China growth concerns, Sensex loses 109 points

Markets trip on China growth concerns, Sensex loses 109 points

Rediff.com11 Jan 2016

FPIs sold shares worth a net Rs 1236.95 crore on Friday.

We are products of the makers of designer food

We are products of the makers of designer food

Rediff.com2 Nov 2016

Now we need to fight back to reclaim our food and our habits. The only way to do so is to rediscover food as pleasure and be thrilled, not just by its smells and tastes, but also by the knowledge it embodies, says Sunita Narain.

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Rediff.com21 Oct 2014

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

Sensex ends below 26K on ECB move; bluechips end in red

Sensex ends below 26K on ECB move; bluechips end in red

Rediff.com4 Dec 2015

Indian markets ended on a lower note after the stimulus announced by the European Central Bank (ECB) failed to meet expectation.

Indian drug regulator threatens to ban Ranbaxy

Indian drug regulator threatens to ban Ranbaxy

Rediff.com29 Jan 2014

A day after getting a show-cause notice from the Indian regulator, senior executives from Ranbaxy Laboratories approached the drug controller's office on Tuesday afternoon, it was learnt.

Markets make handsome gains on monsoon progress, Greece proposal

Markets make handsome gains on monsoon progress, Greece proposal

Rediff.com22 Jun 2015

Most Asian markets ended with gains.

Markets pause after 3-day bull run

Markets pause after 3-day bull run

Rediff.com4 Mar 2016

Asian shares ended higher after a string of positive US economic data.

Ranbaxy brand may fade away as Sun takes charge

Ranbaxy brand may fade away as Sun takes charge

Rediff.com10 Dec 2014

The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.

Sensex rebounds 190 points to end at 23,382

Sensex rebounds 190 points to end at 23,382

Rediff.com17 Feb 2016

The S&P BSE Sensex ended 190 points up at 23,382.

Approval delays to hurt Indian pharma cos' US sales

Approval delays to hurt Indian pharma cos' US sales

Rediff.com13 Nov 2014

Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.

Will Chindia Inc tango?

Will Chindia Inc tango?

Rediff.com13 May 2015

50-odd biz leaders are part of Modi's entourage for the 3-nation tour

Global sell-off casts shadow on D-Street

Global sell-off casts shadow on D-Street

Rediff.com8 Feb 2016

IT shares lost ground tracking a sell-off in tech stocks on Nasdaq on Friday

Weak oil prices drag markets; Nifty ends below 7,400

Weak oil prices drag markets; Nifty ends below 7,400

Rediff.com3 Feb 2016

Financials were the top losers while oil shares also declined amid weak crude oil prices.

Markets end first trading session of 2016 on a tepid note

Markets end first trading session of 2016 on a tepid note

Rediff.com1 Jan 2016

The S&P BSE Sensex closed at 26,190, up by 43 points and Nifty50 settled above 7,950 to end at 7,963, up by 17 points

Markets tumble as China jolts global stocks; IT, banks end in red

Markets tumble as China jolts global stocks; IT, banks end in red

Rediff.com26 Aug 2015

Fear factors weights on markets, Sensex, Nifty struggle to keep pace.

Army hospital in Srinagar gives a new lease of life to flood victims

Army hospital in Srinagar gives a new lease of life to flood victims

Rediff.com20 Sep 2014

At a time when almost the entire healthcare infrastructure in Srinagar city has been rendered ineffective by the devastating floods, the Army's 92 Base Hospital has saved the lives of more than 300 people including 35 newborns.

'For Tamil pride, for Jallikattu'

'For Tamil pride, for Jallikattu'

Rediff.com20 Jan 2017

A Ganesh Nadar watches the fourth day of protests dawn on Chennai's Marina beach.

Corporate India's goodwill deluge to speed up Chennai flood relief

Corporate India's goodwill deluge to speed up Chennai flood relief

Rediff.com6 Dec 2015

Facebook enabled users to mark themselves safe in Chennai since Thursday morning

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

Rediff.com31 Dec 2013

The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.

Another big blow for Ranbaxy

Another big blow for Ranbaxy

Rediff.com22 Aug 2014

Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.

The disconnect between Budget and sector performance

The disconnect between Budget and sector performance

Rediff.com25 Feb 2015

There isn't much Budget could do directly to help sectors.